摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-苯并呋喃-5-羰酰氯 | 56540-70-6

中文名称
1-苯并呋喃-5-羰酰氯
中文别名
1-苯并呋喃-5-甲酰氯
英文名称
benzofuran-5-carbonyl chloride
英文别名
1-Benzofuran-5-carbonyl chloride
1-苯并呋喃-5-羰酰氯化学式
CAS
56540-70-6
化学式
C9H5ClO2
mdl
MFCD03659699
分子量
180.59
InChiKey
HVLITELPDNDMFO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    67-68°C
  • 沸点:
    260.8±13.0 °C(Predicted)
  • 密度:
    1.360±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    30.2
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 安全说明:
    S26,S36/37/39,S45
  • 危险类别码:
    R34
  • 海关编码:
    2932999099
  • 危险品运输编号:
    UN 3265

SDS

SDS:7c47c5a7744015542f65ffc512fe0af9
查看
Name: 1-Benzofuran-5-carbonyl chloride 97% Material Safety Data Sheet
Synonym:
CAS: 56540-70-6
Section 1 - Chemical Product MSDS Name:1-Benzofuran-5-carbonyl chloride 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
56540-70-6 1-Benzofuran-5-carbonyl chloride 97 unlisted
Hazard Symbols: C
Risk Phrases: 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area. Store under an inert atmosphere.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 56540-70-6: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: beige
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 67 - 69 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H5ClO2
Molecular Weight: 180.59

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 56540-70-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1-Benzofuran-5-carbonyl chloride - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3261
Packing Group: III
IMO
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing Group: III
RID/ADR
Shipping Name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3261
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 56540-70-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 56540-70-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 56540-70-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-苯并呋喃-5-羰酰氯copper(l) iodide盐酸羟胺sodium acetate特戊酸钠三乙胺 、 iron(II) chloride 作用下, 以 四氢呋喃1,4-二氧六环乙醇二氯甲烷 为溶剂, 反应 24.0h, 生成 7-(benzofuran-5-yl)-4,4-dimethyl-3,4,5,6-tetrahydro-2H-azepine-2-carbonitrile
    参考文献:
    名称:
    铁催化的亚甲基自由基引发的级联1,5-氢原子转移/(5 + 2)或(5 + 1)环状:肟作为五原子组装单元。
    摘要:
    通过亚胺基引发的1,5-氢原子转移与(5 + 2)或(5 + 1)环化反应的集成,成功制备了一系列结构新颖且有趣的氮杂和螺四氢吡啶衍生物产量。该方法利用FeCl 2作为催化剂,并以易获得的肟为五原子单元,同时显示出广泛的底物范围和良好的官能团相容性。环形产品可以轻松转换成许多有价值的化合物。此外,进行了DFT计算研究,以提供有关(5 + 2)和(5 + 1)环空的可能反应机理的一些见解。
    DOI:
    10.1002/anie.202007825
  • 作为产物:
    描述:
    1-苯并呋喃-5-甲酸草酰氯N,N-二甲基甲酰胺 作用下, 以 二氯甲烷 为溶剂, 反应 4.0h, 生成 1-苯并呋喃-5-羰酰氯
    参考文献:
    名称:
    催化不对称还原三氟烷基化和非对映选择性还原对映选择性合成仲β-三氟甲醇
    摘要:
    氟化基序经常出现在药物和农用化学品中。将含氟基序纳入候选药物以优化药物研发中的先导药物已成为一种强大的工具。具有三氟甲基(CF 3−) 立体生成碳组已积累了广泛的研究成果。与其经过充分探索的具有生物活性的甲基对应物不同,具有相邻立体中心的 β-三氟甲基化醇的不对称结构仍然难以捉摸。通过逆合成分析,我们假设随着羰基的顺序还原,手性 α-三氟甲基化酮的初始构建可以以一种简单的一锅方式提供所需的产品。在此,我们开发了第一个镍催化不对称还原交叉偶联三氟烷基化酰氯的实例,用于对映选择性合成各种α-三氟甲基化酮。这些α-三氟甲基化酮的一锅还原提供了相应的带有β-CF 3的醇-取代的立体碳具有优异的非对映选择性和完全的对映选择性保留。该系统表现出高产率/对映选择性、温和的条件和良好的官能团相容性。该方法的实用性还通过应用生物活性复杂分子的不对称后期三氟烷基化来说明,揭示了开发含 CF 3手性药物的巨大潜力。
    DOI:
    10.1021/jacs.2c01422
点击查看最新优质反应信息

文献信息

  • MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS
    申请人:Combs Andrew Paul
    公开号:US20090286778A1
    公开(公告)日:2009-11-19
    The present invention relates to macrocyclic compounds of Formula I: or pharmaceutically acceptable salts thereof or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are JAK/ALK inhibitors useful in the treatment of JAK/ALK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
    本发明涉及以下化学式I的大环化合物: 或其药用可接受盐或季铵盐,其中所述成员在此提供,并且它们的组成物和使用方法,这些JAK/ALK抑制剂在治疗JAK/ALK相关疾病中有用,例如炎症和自身免疫性疾病以及癌症。
  • Palladium‐Catalyzed Chlorocarbonylation of Aryl (Pseudo)Halides Through In Situ Generation of Carbon Monoxide
    作者:Philip Boehm、Sven Roediger、Alessandro Bismuto、Bill Morandi
    DOI:10.1002/anie.202005891
    日期:2020.10.5
    efficient palladiumcatalyzed chlorocarbonylation of aryl (pseudo)halides that gives access to a wide range of carboxylic acid derivatives has been developed. The use of butyryl chloride as a combined CO and Cl source eludes the need for toxic, gaseous carbon monoxide, thus facilitating the synthesis of high‐value products from readily available aryl (pseudo)halides. The combination of palladium(0), Xantphos
    已经开发了一种有效的钯催化的芳基(假)卤化物的氯羰基化反应,该反应可以使用多种羧酸衍生物。使用丁酰氯作为CO和Cl的混合来源,就不需要有毒的气态一氧化碳,从而促进了从容易获得的芳基(伪)卤化物合成高价值产品的需求。钯(0),黄药和胺碱的组合对于促进这种广泛适用的催化反应至关重要。总体而言,该反应可通过原位生成的芳酰氯的转化获得多种含羰基的产物。结合实验和计算研究,可以支持涉及原位生成CO的反应机理。
  • Benzoxazole carboxamides for treating CINV and IBS-D
    申请人:Fairfax J. David
    公开号:US20060183769A1
    公开(公告)日:2006-08-17
    Compounds of formulae I and II: are disclosed as 5-HT 3 inhibitors. Those compounds that exhibit central activity are useful in treating CINV; those that inhibit peripheral receptors are useful to treat IBS-D.
    公式I和II的化合物: 被披露为5-HT3受体拮抗剂。那些表现出中枢活性的化合物对治疗CINV有用;那些抑制外周受体的化合物对治疗IBS-D有用。
  • Ni‐Catalyzed Direct Carboxylation of Aryl C−H Bonds in Benzamides with CO <sub>2</sub>
    作者:Chunzhe Pei、Jiarui Zong、Bin Li、Baiquan Wang
    DOI:10.1002/adsc.202101285
    日期:2022.2
    The direct carboxylation of inert aryl C−H bond catalyzed by abundant and cheap nickel is still facing challenge. Herein, we report the Ni-catalyzed direct carboxylation of aryl C−H bonds in benzamides under 1 atm of CO2 to afford various methyl carboxylates or phthalimides, dealing with different post-processing. The reaction displays excellent functional group tolerance and affords moderate to high
    丰富且廉价的镍催化惰性芳基 C-H 键直接羧化仍面临挑战。在此,我们报道了在 1 个大气压的 CO 2下 Ni 催化的苯甲酰胺中芳基 C-H 键的直接羧化反应,得到各种羧酸甲酯或邻苯二甲酰亚胺,并进行了不同的后处理。该反应表现出优异的官能团耐受性,并在温和条件下提供中等至高的羧化产率。详细的机理研究表明,Ni(0)-Ni(II)-Ni(I) 催化循环可能参与该反应。
  • PHENYLPROPIONIC ACID DERIVATIVE AND USE THEREOF
    申请人:MORITA Kohei
    公开号:US20100093819A1
    公开(公告)日:2010-04-15
    A compound represented by the following general formula (1) or a salt thereof, which has superior inhibitory activity against type 4 PLA 2 , and thus has prostaglandin and/or leucotriene production suppressing action [X represents a halogen atom, an alkyl group which may be substituted, or the like, Y represents hydrogen atom or an alkyl group which may be substituted, and Z represents hydrogen atom or an alkyl group which may be substituted].
    由以下一般式(1)表示的化合物或其盐,具有优越的抑制对4型PLA2的活性,因此具有前列腺素和/或白三烯产生抑制作用【X代表卤素原子、可能被取代的烷基或类似物,Y代表氢原子或可能被取代的烷基,Z代表氢原子或可能被取代的烷基】。
查看更多

同类化合物

顺式-1-((2-(5-氯-2-苯并呋喃基)-4-甲基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 顺式-1-((2-(5,7-二氯-2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-咪唑 顺式-1-((2-(2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 霉酚酸酯杂质B 间甲酚紫 间甲基苯基(苯并呋喃-2-基)甲醇 长管假茉莉素C 金霉素 酪氨酸,b-羰基- 酞酸酐-d4 酚酞二丁酸酯 酚酞 酚红钠 酚红 邻苯二甲酸酐与马来酸酐,甘氨酰蜡素和二乙二醇的聚合物 邻苯二甲酸酐与己二醇的聚合物 邻苯二甲酸酐与三甘醇异壬醇的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇和2,5-呋喃二酮的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇、2,5-呋喃二酮和2-乙基己酸苯甲酸酯的聚合物 邻苯二甲酸酐-4-硼酸频哪醇酯 邻苯二甲酸酐,马来酸,二乙二醇,新戊二醇聚合物 邻甲酚酞 贝康唑 表灰黄霉素 螺佐呋酮 螺[苯并呋喃-3(2H),4-哌啶] 螺[异苯并呋喃-1(3H),4’-哌啶]-3-酮 螺[异苯并呋喃-1(3H),4'-哌啶]-3-酮盐酸盐 螺[异苯并呋喃-1(3H),3’-吡咯烷]-3-酮 螺[1-苯并呋喃-2,1'-环丙烷]-3-酮 薄荷内酯 莫罗卡尼 荨麻叶泽兰酮 荧光胺 苯酞-3-乙酸 苯酐二乙二醇共聚物 苯酐 苯甲酸,2-[(1,3-二羰基丁基)氨基]-,甲基酯 苯甲酸,2,2-二(羟甲基)丙烷-1,3-二醇,异苯并呋喃-1,3-二酮 苯甲酰氯化,3-甲氧基-4-甲基- 苯甲基(1-{(2-amino-2-methylpropanoyl)[(2S)-2-aminopropanoyl]amino}-2-methyl-1-oxopropan-2-yl)甲基氨基甲酸酯(non-preferredname) 苯并呋喃并[3,2-d]嘧啶-2,4(1H,3H)-二酮 苯并呋喃并[3,2-D]嘧啶-4(1H)-酮 苯并呋喃并[2,3-d]哒嗪-4(3H)-酮 苯并呋喃并(3,2-c)吡啶,1,2,3,4-四氢-2-(2-(二甲氨基)乙基)-,二盐酸 苯并呋喃与1H-茚的聚合物 苯并呋喃[3,2-b]吡咯-2-羧酸 苯并呋喃-7-羧酸 苯并呋喃-7-硼酸频那醇酯 苯并呋喃-7-甲腈